CHEMED CORPORATION vs FRESENIUS MEDICAL CARE AG, two Medical Care stocks. A side-by-side on valuation, growth, margins, returns, and what each price is betting.
Where CHE and FMS diverge most: on p/b, CHE reads 7.93 and FMS reads 0.79; on altman z (solvency), CHE reads 9.81 and FMS reads 1.72. The rest of the comparable metrics sit closer together. What CHE's price implies is a bet that sits within the historical range (whole-company basis). What FMS's price implies is a bet that sits within the historical range (whole-company basis). The bull and bear cases for each are in their full reports below.
| Metric | CHE | FMS |
|---|---|---|
| Price | $499.14 | $21.05 |
| Market cap | $6.6B | $12.3B |
| Sector | Medical Care | Medical Care |
| Stage | Mature | Mature |
| Implied growth (priced in) | +4.7% | — |
| P/E | 25.1 | 11.5 |
| P/B | 7.93 | 0.79 |
| P/S | 2.54 | 0.58 |
| EV/EBITDA | 16.4 | 5.2 |
| Revenue growth | +3.4% | +1.5% |
| Operating margin | 13.3% | 11.7% |
| Net margin | 10.6% | 6.1% |
| Return on equity | 33.1% | 8.3% |
| Return on assets | 17.4% | 3.8% |
| Return on invested capital | 26.7% | 6.7% |
| FCF yield | 4.7% | 23.7% |
| Dividend yield | 0.4% | 1.9% |
| Debt / equity | 0.17 | 0.51 |
| Current ratio | 0.91 | 1.26 |
| Altman Z (solvency) | 9.81 | 1.72 |
| Piotroski F (quality) | 6 / 9 | 8 / 9 |
Each week boothcheck ranks the stocks whose prices are betting on the most. Read the most stretched bets archive →
boothcheck is also on Android. Get the app on Google Play →
The stronger value is highlighted per metric where one is strictly better on that single number; it is not an overall verdict on either company. For informational and research purposes only. Not investment advice. Not a recommendation to buy, sell, or hold any security. boothcheck is not a registered investment adviser. Past performance does not guarantee future results.